Tag Archives: Mice Model Market

Mice Model Market – Current status and future trends

Global Mice Model Market: Snapshot

Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nation’s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. This forms the primary driver for the global mice models market.

Another factor promoting the increased use of mice models is the recent number of improvements that have been made in mice models. These improvements have not only enhanced their utility in current applications, but also increased the overall scope of applications for mice models. Biomedical research can use mice models for increasingly complex diseases, such as the use of mutated mice models for studying the ALS disease, or the use of advanced mice models to understand lung injury repair.

This 155 page report gives readers a comprehensive overview of the mice model market. Browse through 20 data tables and 79 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/mice-model-market.html

The factors above and similar ones that promote the use of mice models are responsible for imparting a positive growth rate to the global mice models market, which is expected to be valued at US$1.79 bn by the end of 2023.

Demand for Mice Models in North America Remains High

44.9% of the global market for mice models is expected to be held by North America in 2023, in terms of revenue. Europe at the same time is expected to emerge as the second-leading market for mice models, followed closely by Asia Pacific. North America and Europe have an established pharmaceutical industry and an advanced biosciences research field. Both regions are still showing a high demand for mice models that are meant to be used in advanced drug discovery processes and other medical research.

However, their overall share in the market value has dropped since 2014, owing to the significantly high demand for mice models in Asia Pacific. This region is showing an especially high demand for knockout and transgenic mice models. Close to half of the global mice models business in the world for these types is taken up by the Asia Pacific countries of China, India, Malaysia, and Singapore.

Inbred Mice Models Continue to Show High Demand, Demand for Hybrid Models on the Rise

Request a sample of this report to know what opportunities will emerge in the rapidly evolving mice model market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

Based on model types, the global market for mice models is expected to progress at a CAGR of 6.4% from 2015 to 2023, ending at US$1.79 bn by the end of 2023. Among the various mice model types, inbred mice models have consistently been the popular ones, owing to the ease with which scientists can reproduce the data and the overall cost effective system of obtaining inbred mice models. Additionally, the size of samples in inbred mice models can be considerably smaller than their outbred counterparts.

However, the demand for congenic or hybrid mice models is expected to rise significantly over the coming years owing to a high preference for them in the expanding cardiovascular research. Transgenic mice models are the second most popular models in the world. They possess a high volume of research capability in the fields of angiogenesis, breast cancer, and Alzheimer’s disease.

The key providers of mice models from a global standpoint include Charles River Laboratories, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences.

 

Mice Model Market: Expected Advancements & Global Industry Analysis 2023

Global Mice Model Market: Snapshot

Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nation’s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. This forms the primary driver for the global mice models market.

Another factor promoting the increased use of mice models is the recent number of improvements that have been made in mice models. These improvements have not only enhanced their utility in current applications, but also increased the overall scope of applications for mice models. Biomedical research can use mice models for increasingly complex diseases, such as the use of mutated mice models for studying the ALS disease, or the use of advanced mice models to understand lung injury repair.

This 155 page report gives readers a comprehensive overview of the mice model market. Browse through 20 data tables and 79 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/mice-model-market.html

The factors above and similar ones that promote the use of mice models are responsible for imparting a positive growth rate to the global mice models market, which is expected to be valued at US$1.79 bn by the end of 2023.

Demand for Mice Models in North America Remains High

44.9% of the global market for mice models is expected to be held by North America in 2023, in terms of revenue. Europe at the same time is expected to emerge as the second-leading market for mice models, followed closely by Asia Pacific. North America and Europe have an established pharmaceutical industry and an advanced biosciences research field. Both regions are still showing a high demand for mice models that are meant to be used in advanced drug discovery processes and other medical research.

However, their overall share in the market value has dropped since 2014, owing to the significantly high demand for mice models in Asia Pacific. This region is showing an especially high demand for knockout and transgenic mice models. Close to half of the global mice models business in the world for these types is taken up by the Asia Pacific countries of China, India, Malaysia, and Singapore.

Inbred Mice Models Continue to Show High Demand, Demand for Hybrid Models on the Rise

Request a sample of this report to know what opportunities will emerge in the rapidly evolving mice model market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

Based on model types, the global market for mice models is expected to progress at a CAGR of 6.4% from 2015 to 2023, ending at US$1.79 bn by the end of 2023. Among the various mice model types, inbred mice models have consistently been the popular ones, owing to the ease with which scientists can reproduce the data and the overall cost effective system of obtaining inbred mice models. Additionally, the size of samples in inbred mice models can be considerably smaller than their outbred counterparts.

However, the demand for congenic or hybrid mice models is expected to rise significantly over the coming years owing to a high preference for them in the expanding cardiovascular research. Transgenic mice models are the second most popular models in the world. They possess a high volume of research capability in the fields of angiogenesis, breast cancer, and Alzheimer’s disease.

The key providers of mice models from a global standpoint include Charles River Laboratories, The Jackson Laboratory, Harlan Laboratories, and Taconic Biosciences.

 

Mice Model Market Current Scenario Analysis with Forecast by 2023

The extremely consolidated global market for mice models is primarily dominated by the players Charles River, The Jackson Laboratory, and Harlan Laboratories – three companies that collectively occupied 75% of the market in 2014 in terms of value.

At the time, the market was predominantly controlled by a small number of players, mostly owing to the disparity in demand between developed and developing economies. However, as the rate of development of emerging economies and their biomedical industries ramps up, so does their demand for mice models.

The resultant effect on the competitive landscape for the global mice models market is a significant growth in the number of regional players in the emerging economies. They pose a direct threat to the globally prominent players that are trying to invest in the opportunities that these regions hold.

According to a new publication by Transparency Market Research, the trend of outsourcing mice models to CROs and pharma companies is also driving the global demand for mice models.

This 155 page report gives readers a comprehensive overview of the mice model market. Browse through 20 data tables and 79 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/mice-model-market.html

There is, however, considerable strain on the market’s growth rate due to the stringent regulations applied by global healthcare and pharmaceutical bodies.

Advancements in Mice Model Types and Services Add to Research Scope and Capabilities

“The ALS Association had recently shown the use of mutated mice models for the study of the disease,” states a TMR analyst. “This is only one of the many examples that can show that the recent advancements in mice model types and services have not only added to the strength of existing research processes, but have also expanded the scope of mice model use within other medical research fields.”

New mice models are found to be acceptable in the studies of advanced diseases, a fact which is greatly driving the demand for mice models. They can now be used in advanced research such as lung disease repair.

The integral nature of the mice models market with the pharmaceutical and biomedical fields has allowed companies from these industries to form alliances that can even revolve around further advancing the mice models types and services in the future.

Growing Scope of Alternative Technologies Restrains Use of Mice Models

A lot of companies are currently seeking non-animal test methods for their research processes in order to either eliminate animal use completely or to restrict it as much as possible. Alternatives include solutions such as the Irritation Assay System which is a simplified procedure in a test tube used for skin irritation, or even human skin culture.

A lot of these alternatives are not only cheaper but also provide a faster and more accurate conclusion formation process. This complements the reduction in use of animal models due to the growing protests by people against their use.

In another alternative, professionals are adopting computer-generated simulations to test their processes, further reducing the need for animal models.

North America Retains Leading Demand for Mice Models While APAC Demand Soars

The global market for mice models is expected to be evaluated at US$1.79 bn by the end of 2023

Request a sample of this report to know what opportunities will emerge in the rapidly evolving mice model market during 2015 – 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

North America has consistently been a key region in terms of demand for mice models. By the end of 2023, this region is expected to generate a revenue of US$785.4 mn. Meanwhile, the demand for mice models is expected to expand at a CAGR of 11.1% in Asia Pacific, from 2015 to 2023.

An immense demand for genetically engineered mice models is expected to put this service type in the leading position by 2023, with an expected revenue of US$155.2 mn. Mouse breeding and re-derivation have so far been the more popular mice model service types but are likely to be replaced by genetically engineered models soon.

Inbred mice models have consistently been the more popular mice model types. By the end of 2023, the revenue earned by the inbred mice model segment is expected to reach US$340.6 mn.

The information presented in this review is based on a Transparency Market Research report, titled, “Mice Model Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023.”

 Key Takeaways:

  • By 2023, inbred mice models are expected to generate a revenue of US$340.6 mn.
  • Genetically engineered mice is expected to be the leading service by 2023. By 2023, its revenue is expected to reach US$155.2 mn.
  • North America is expected to continue leading the consumption amount and rate till 2023. By 2023, North America will generated a revenue of US$785.4 mn in mice models.

 

Mice Model Market Current Scenario Analysis with Forecast by 2023

In the last couple of decades, mouse modelling has emerged as a premier mammalian model system for conducting effective genetic research. Mice models have long remained the basis of fundamental and applied research in life science, and are continuing to exhibit robust growth. Due to the close psychological and genetic similarities between mice and humans, scientists hailing from diverse biomedical fields have gravitated to mice models. Furthermore, the ease with which the genomes of mice can be manipulated and analyzed has also given a boost to the global mice model market.

In its latest report, Transparency Market Research has pegged the overall value of the global mice model at US$1 bn in 2014. The market is projected to reach US$1.7 bn by the end of 2023. If the figures hold true, the global mice model market will exhibit a 6.4% CAGR between 2015 and 2023. Although worms, yeasts, and flies are considered excellent models for scrutinizing the cell cycle and development process, mice have proven to be a far better tool for studying the nervous, skeletal, cardiovascular, endocrine, immune, and other complex physiological systems that mammals share.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

Genetic Similarities of Mice with Other Mammals Boost Market for Mice Model

Like humans and several other mammals, mice often develop diseases that negatively affecttheir immune systems such as cancer, diabetes, oestoporasis, hypertension, glaucoma, and others. Furthermore, certain diseases that affect humans but do not naturally occur in mice, such as Alzheimer’s and cystic fibrosis, can be induced in mice by manipulating their genome to study the effect of novel therapeutics in the treatment of such ailments. The demand for mice model, therefore, increases with the rising funding in research and development to find possible cures for chronic ailments.

Mice present low cost of maintenance and have the ability to multiply rapidly, reproducing as often as nine weeks. This further adds to their appeal as models for biomedical research.

Development of New Therapeutics with Mice Models Propels Mice Model Market

Development of mice models for studying the effects of potential therapeutics in the treatment of certain specific diseases and debilitating health conditions has accelerated tremendously in the last couple of years. The development has been so rapid that mice models have become indispensable in the evaluation of both pipeline and established treatment modalities, particularly in cases of cardiovascular diseases, cancer, neurological disorders, and metabolic anomalies.

Application of mice models in drug discovery enables the development of novel therapeutics strategies, target identification and validation, disease treatment, drug screening, and toxicity and safety screening.

Ethical Issues and Stringent Regulations Hinder Global Mice Model Market

The latest advances in genetic engineering that assist in evaluating a drug’s mechanism of action will boost the market for drug discovery. This in turn is likely to fuel demand from the mice model market. However, on the flip side, stringent regulatory frameworks precisely controlling the use of animals for research in laboratories, rising concerns pertaining to animal cruelty, and other ethical concerns related to the use of animals will have an adverse impact on the overall mice model market.

Global Mice Model Market to Rise to US$1.7 bn by 2023 due to Growing Research Efforts in Gene Tech

Mice model marketMice models have long been the backbone of fundamental and applied research in life sciences and continues to grow at a rapid rate. The mice model market has transformed since 2001, the year rodent genome was mapped. Mice models have a wide array of applications such as basic research, developing new therapeutic strategies for the treatment of human diseases, drug discovery and development research (such as target characterization, drug screening, and toxicity and safety evaluation), and preclinical studies of drug efficacy. Hundreds of mice models have been developed to study diseases such as cancer, Huntington’s, Parkinson’s, Duchenne and Becker muscular dystrophy, and amyotrophic lateral sclerosis (ALS). In the last 25 years, around 80% of discoveries in the biomedical research has been linked to research on mice.

The global mice model market was valued at USD 1,008.1 million in 2014 and is projected to reach USD 1,749.3 million in 2023, expanding at a CAGR of 6.4% from 2015 to 2023. Major factor boosting the growth of the market is the growing application of mice models not only in the field of basic research, but also in applied field of drug development and discovery. Development of mice models of human diseases has progressed rapidly in the past few years. Mice model has become indispensable in the evaluation of established and experimental treatment strategies, especially in cancer, cardiovascular diseases, metabolic anomalies, and neurological disorders. Mice model applications in drug discovery include development of new therapeutic strategies for the treatment of human diseases, target identification and validation, drug screening and lead optimization, and toxicity and safety screening. Furthermore, advancements in genetic engineering assisting in evaluating drug mechanism of action and its responses are expected to impact the growth of the drug discovery market. On the other hand, factors such as stringent regulatory framework that require precise control on use of animals in laboratories, rising concern on animal cruelty, and ethical concerns over the use of animals could negatively impact market growth.

The mice model market has been segmented into three major categories: model type, specialty, and services. Based on model type, inbred was the largest segment of the global mice model market in 2014 due to advantages such as cost effectiveness and data reproducibility. Metabolic & regulatory diseases was the largest specialty segment of the mice model market in terms of revenue in 2014. The segment accounted for 29.6% share of the market in 2014. The mice model services market is anticipated to expand at a CAGR of 7.3% from 2015 to 2023. The cryopreservation and cryorecovery services segment would expand at the highest growth rate during the forecast period as it requires less investment to maintain mice strain for a longer time.

Downlaod Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2085

Based on geography, the mice model market has been segmented into North America, Europe, Asia Pacific, Latin America, MENA, and Rest of the World (RoW). North America was the largest market for mice model in 2014. Ongoing robust research activities for the development of drugs and biologics and presence of major pharmaceutical and biotechnology companies in the region are some of the factors responsible for the dominance of the region. Europe held the second largest share of the global mice model market in terms of revenue in 2014. Asia Pacific is expected to be the fastest growing market for mice model during the forecast period from 2015 to 2023. This high growth is primarily due to improving economic condition in countries such as India and China, and increasing number of academic and research, and contract research organizations in Asia Pacific. Japan, China, Australia, and India are the major markets in Asia Pacific that offer immense opportunities to companies in the mice model market. Continuous increase in biomedical research expenditure in China and India are expected to play a key role in fueling the growth in these markets. The market in MENA, Rest of the World (RoW) and Latin America would also grow significantly due to increasing public and private investment in biomedical researches. In addition, factors such as improving health care infrastructure, rising awareness, and flexible regulatory requirements in the region are driving the mice model market.

Key players operating in the global mice model market include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., genOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, and TransGenic, Inc.